Ngā hua rapu - Sufeng Mao
- E whakaatu ana i te 1 - 11 hua o te 11
-
1
-
2
-
3
-
4
CELF1 is a central node in post-transcriptional regulatory programmes underlying EMT mā Arindam Chaudhury, Shebna A. Cheema, Joseph M. Fachini, Natee Kongchan, Guojun Lu, Lukas M. Simon, Tao Wang, Sufeng Mao, Daniel Rosen, Michael Ittmann, Susan G. Hilsenbeck, Chad A. Shaw, Joel R. Neilson
I whakaputaina 2016Artigo -
5
A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer mā Hariprasad Thangavel, Carmine De Angelis, Suhas Vasaikar, Raksha R. Bhat, Mohit Kumar Jolly, Chandandeep Nagi, Chad J. Creighton, Fengju Chen, Lacey E. Dobrolecki, Jason T. George, Tanya Kumar, Noor Mazin Abdulkareem, Sufeng Mao, Agostina Nardone, Mothaffar F. Rimawi, C. Kent Osborne, Michael T. Lewis, Herbert Levine, Bing Zhang, Rachel Schiff, Mario Giuliano, Meghana V. Trivedi
I whakaputaina 2019Artigo -
6
Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy mā Mario Giuliano, Huizhong Hu, Yen-Chao Wang, Xiaoyong Fu, Agostina Nardone, Sabrina Herrera, Sufeng Mao, Alejandro Contreras, Carolina Gutiérrez, Tao Wang, Susan G. Hilsenbeck, Carmine De Angelis, Nicholas J. Wang, Laura M. Heiser, Joe W. Gray, Sara López‐Tarruella, Anne C. Pavlick, Meghana V. Trivedi, Gary C. Chamness, Jenny C. Chang, C. Kent Osborne, Mothaffar F. Rimawi, Rachel Schiff
I whakaputaina 2015Artigo -
7
Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis mā Mario Giuliano, Sabrina Herrera, Pavel Christiny, Chad A. Shaw, Chad J. Creighton, Tamika Mitchell, Raksha R. Bhat, Xiaomei Zhang, Sufeng Mao, Lacey E. Dobrolecki, Ahmed Al-Rawi, Fengju Chen, Bianca Maria Veneziani, Xiang H.-F. Zhang, Susan G. Hilsenbeck, Alejandro Contreras, Carolina Gutiérrez, Rinath Jeselsohn, Mothaffar F. Rimawi, C. Kent Osborne, Michael T. Lewis, Rachel Schiff, Meghana V. Trivedi
I whakaputaina 2015Artigo -
8
Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy mā Carmine De Angelis, Chandandeep Nagi, Cliff C. Hoyt, Linying Liu, Kristin Roman, Chichung Wang, Yi Zheng, Jamunarani Veeraraghavan, Vidyalakshmi Sethunath, Paolo Nucíforo, Tao Wang, Anna Tsimelzon, Sufeng Mao, Susan G. Hilsenbeck, Meghana V. Trivedi, Maria Letizia Cataldo, Anne C. Pavlick, Antonio C. Wolff, Britta Weigelt, Jorge S. Reis‐Filho, Aleix Prat, Carolina Gutiérrez, C. Kent Osborne, Mothaffar F. Rimawi, Rachel Schiff
I whakaputaina 2019Artigo -
9
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models mā Xiaomei Zhang, Sofie Claerhout, Aleix Prat, Lacey E. Dobrolecki, Ivana Petrović, Qing Lai, Melissa D. Landis, Lisa Wiechmann, Rachel Schiff, Mario Giuliano, Helen Wong, Suzanne A.W. Fuqua, Alejandro Contreras, Carolina Gutiérrez, Jian Huang, Sufeng Mao, Anne C. Pavlick, Amber M. Froehlich, Meng-Fen Wu, Anna Tsimelzon, Susan G. Hilsenbeck, Edward S. Chen, Pavel Zuloaga, Chad A. Shaw, Mothaffar F. Rimawi, Charles M. Perou, Gordon B. Mills, Jenny C. Chang, Michael T. Lewis
I whakaputaina 2013Artigo -
10
Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer mā Amritha Nair, Hsiang-Ching Chung, Tingting Sun, Siddhartha Tyagi, Lacey E. Dobrolecki, Rocío Domínguez-Vidaña, Sarah J. Kurley, Mayra Orellana, Alexander Renwick, David Henke, Panagiotis Katsonis, Earlene M. Schmitt, Doug W. Chan, Hui Li, Sufeng Mao, Ivana Petrović, Chad J. Creighton, Carolina Gutiérrez, Julien Dubrulle, Fabio Stossi, Jeffrey W. Tyner, Olivier Lichtarge, Charles Y. Lin, Bing Zhang, Kenneth L. Scott, Susan G. Hilsenbeck, Jin‐Peng Sun, Xiao Yu, C. Kent Osborne, Rachel Schiff, James G. Christensen, David J. Shields, Mothaffar F. Rimawi, Matthew J. Ellis, Chad A. Shaw, Michael T. Lewis, Thomas F. Westbrook
I whakaputaina 2018Artigo -
11
Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors mā Xiangdong Lv, Xuan Lu, Jin Cao, Qin Luo, Yao Ding, Fanglue Peng, Apar Pataer, Dong Lu, Dong Han, Eric Malmberg, Doug W. Chan, Xiaoran Wang, Sara R. Savage, Sufeng Mao, Jingjing Yu, Fei Peng, Yan Liang, Huan Meng, Laure Maneix, Han Yu-min, Yiwen Chen, Wantong Yao, Eric C. Chang, André Catic, Xia Lin, George Miles, Pengxiang Huang, Zheng Sun, Bryan M. Burt, Huamin Wang, Jin Wang, Qizhi Yao, Bing Zhang, Jack A. Roth, Bert W. O’Malley, Matthew J. Ellis, Mothaffar F. Rimawi, Haoqiang Ying, Xi Chen
I whakaputaina 2023Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Biology
Breast cancer
Cancer
Cancer research
Medicine
Internal medicine
Oncology
Gene
Pathology
Estrogen receptor
Genetics
Immunohistochemistry
Cell biology
Endocrinology
Biochemistry
Downregulation and upregulation
Estrogen
Hyperplasia
Lapatinib
Metastasis
Phosphorylation
Progesterone receptor
Receptor
Trastuzumab
Triple-negative breast cancer
Amphiregulin
Biotechnology
CD20
Carcinoma
Chemistry